Skye Bioscience, Inc.SKYENASDAQ
LOADING
|||
Current Ratio Over Time
Trending higher, above historical average, strong compound growth.
Left:
||||
Current ratio (current assets / current liabilities)
Latest
16.32
↑ 395% above average
Average (9y)
3.30
Historical baseline
Range
High:16.32
Low:0.12
CAGR
+11.9%
Consistent expansion
| Period | Value | Change |
|---|---|---|
| 2024 | 16.32 | +1847.6% |
| 2023 | 0.84 | +13.6% |
| 2022 | 0.74 | -70.0% |
| 2021 | 2.46 | -27.4% |
| 2020 | 3.38 | +64.7% |
| 2019 | 2.05 | +1576.3% |
| 2018 | 0.12 | -82.2% |
| 2017 | 0.69 | +63.3% |
| 2016 | 0.42 | -92.9% |
| 2015 | 5.94 | - |